Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Arthritis & Rheumatology (Hoboken, N.J.)|November 27, 2019
Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Patients With Active Systemic Lupus ErythematosusRonald F van Vollenhoven, Bevra H Hahn, George C Tsokos, et al.
Journal of Translational Medicine|September 17, 2014
Characterization of immune cells in psoriatic adipose tissueShawn Rose, Elena Stansky, Pradeep K Dagur, et al.
Journal of Translational Medicine|June 12, 2016
ApoE deficiency exacerbates the development and sustainment of a semi-chronic K/BxN serum transfer-induced arthritis modelAmy M Archer, Rana Saber, Shawn Rose, et al.
American Journal of Cardiovascular Disease|November 14, 2013
A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot studyShawn Rose, Nikhil H Sheth, Joshua F Baker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2015
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte ActivationDavid A Zidar, Steven Juchnowski, Brian Ferrari, et al.
The Journal of Rheumatology|December 2, 2021
Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension StudyRonald F van Vollenhoven, Bevra H Hahn, George C Tsokos, et al.
Lancet (London, England)|September 26, 2018
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled studyRonald F van Vollenhoven, Bevra H Hahn, George C Tsokos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2020
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus ErythematosusMatteo Cesaroni, Loqmane Seridi, Matthew J Loza, et al.
Pageof 2